227 related articles for article (PubMed ID: 15522446)
1. Rescue of Ebola virus from cDNA using heterologous support proteins.
Theriault S; Groseth A; Neumann G; Kawaoka Y; Feldmann H
Virus Res; 2004 Nov; 106(1):43-50. PubMed ID: 15522446
[TBL] [Abstract][Full Text] [Related]
2. A reconstituted replication and transcription system for Ebola virus Reston and comparison with Ebola virus Zaire.
Boehmann Y; Enterlein S; Randolf A; Mühlberger E
Virology; 2005 Feb; 332(1):406-17. PubMed ID: 15661171
[TBL] [Abstract][Full Text] [Related]
3. Interactions of Marburg virus nucleocapsid proteins.
Becker S; Rinne C; Hofsäss U; Klenk HD; Mühlberger E
Virology; 1998 Sep; 249(2):406-17. PubMed ID: 9791031
[TBL] [Abstract][Full Text] [Related]
4. Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication.
Hartman AL; Dover JE; Towner JS; Nichol ST
J Virol; 2006 Jul; 80(13):6430-40. PubMed ID: 16775331
[TBL] [Abstract][Full Text] [Related]
5. Rapid detection protocol for filoviruses.
Weidmann M; Mühlberger E; Hufert FT
J Clin Virol; 2004 May; 30(1):94-9. PubMed ID: 15072761
[TBL] [Abstract][Full Text] [Related]
6. A filovirus-unique region of Ebola virus nucleoprotein confers aberrant migration and mediates its incorporation into virions.
Shi W; Huang Y; Sutton-Smith M; Tissot B; Panico M; Morris HR; Dell A; Haslam SM; Boyington J; Graham BS; Yang ZY; Nabel GJ
J Virol; 2008 Jul; 82(13):6190-9. PubMed ID: 18417588
[TBL] [Abstract][Full Text] [Related]
7. Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity.
Volchkov VE; Volchkova VA; Muhlberger E; Kolesnikova LV; Weik M; Dolnik O; Klenk HD
Science; 2001 Mar; 291(5510):1965-9. PubMed ID: 11239157
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of Ebola virus VP24 impairs viral nucleocapsid assembly and prevents virus replication.
Mateo M; Carbonnelle C; Martinez MJ; Reynard O; Page A; Volchkova VA; Volchkov VE
J Infect Dis; 2011 Nov; 204 Suppl 3():S892-6. PubMed ID: 21987766
[TBL] [Abstract][Full Text] [Related]
9. Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24.
Hoenen T; Groseth A; Kolesnikova L; Theriault S; Ebihara H; Hartlieb B; Bamberg S; Feldmann H; Ströher U; Becker S
J Virol; 2006 Jul; 80(14):7260-4. PubMed ID: 16809331
[TBL] [Abstract][Full Text] [Related]
10. RNA polymerase I-driven minigenome system for Ebola viruses.
Groseth A; Feldmann H; Theriault S; Mehmetoglu G; Flick R
J Virol; 2005 Apr; 79(7):4425-33. PubMed ID: 15767442
[TBL] [Abstract][Full Text] [Related]
11. Complete genome sequence of an Ebola virus (Sudan species) responsible for a 2000 outbreak of human disease in Uganda.
Sanchez A; Rollin PE
Virus Res; 2005 Oct; 113(1):16-25. PubMed ID: 16139097
[TBL] [Abstract][Full Text] [Related]
12. Ebola virus (EBOV) VP24 inhibits transcription and replication of the EBOV genome.
Watanabe S; Noda T; Halfmann P; Jasenosky L; Kawaoka Y
J Infect Dis; 2007 Nov; 196 Suppl 2():S284-90. PubMed ID: 17940962
[TBL] [Abstract][Full Text] [Related]
13. Crystal Structure of the Marburg Virus Nucleoprotein Core Domain Chaperoned by a VP35 Peptide Reveals a Conserved Drug Target for Filovirus.
Zhu T; Song H; Peng R; Shi Y; Qi J; Gao GF
J Virol; 2017 Sep; 91(18):. PubMed ID: 28659479
[TBL] [Abstract][Full Text] [Related]
14. Blockage of filoviral glycoprotein processing by use of a protein-based inhibitor.
Ströher U; Willihnganz L; Jean F; Feldmann H
J Infect Dis; 2007 Nov; 196 Suppl 2():S271-5. PubMed ID: 17940960
[TBL] [Abstract][Full Text] [Related]
15. Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections.
Swenson DL; Warfield KL; Negley DL; Schmaljohn A; Aman MJ; Bavari S
Vaccine; 2005 Apr; 23(23):3033-42. PubMed ID: 15811650
[TBL] [Abstract][Full Text] [Related]
16. Ebolavirus and Marburgvirus: insight the Filoviridae family.
Ascenzi P; Bocedi A; Heptonstall J; Capobianchi MR; Di Caro A; Mastrangelo E; Bolognesi M; Ippolito G
Mol Aspects Med; 2008 Jun; 29(3):151-85. PubMed ID: 18063023
[TBL] [Abstract][Full Text] [Related]
17. Regions in Ebola virus VP24 that are important for nucleocapsid formation.
Noda T; Halfmann P; Sagara H; Kawaoka Y
J Infect Dis; 2007 Nov; 196 Suppl 2():S247-50. PubMed ID: 17940956
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of filovirus replication by the zinc finger antiviral protein.
Müller S; Möller P; Bick MJ; Wurr S; Becker S; Günther S; Kümmerer BM
J Virol; 2007 Mar; 81(5):2391-400. PubMed ID: 17182693
[TBL] [Abstract][Full Text] [Related]
19. Sudan Ebolavirus VP35-NP Crystal Structure Reveals a Potential Target for Pan-Filovirus Treatment.
Landeras-Bueno S; Oda SI; Norris MJ; Li Salie Z; Guenaga J; Wyatt RT; Saphire EO
mBio; 2019 Jul; 10(4):. PubMed ID: 31337716
[TBL] [Abstract][Full Text] [Related]
20. Rescue of recombinant Marburg virus from cDNA is dependent on nucleocapsid protein VP30.
Enterlein S; Volchkov V; Weik M; Kolesnikova L; Volchkova V; Klenk HD; Mühlberger E
J Virol; 2006 Jan; 80(2):1038-43. PubMed ID: 16379005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
